{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:29:46Z","timestamp":1792024186718,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Medical Association of Sichuan Province, China","award":["Grant No. S22052"],"award-info":[{"award-number":["Grant No. S22052"]}]},{"name":"The Joint Innovation Project of the Department of Science and Technology of Sichuan Province, China","award":["Grant No. 2022YFS0610"],"award-info":[{"award-number":["Grant No. 2022YFS0610"]}]},{"name":"The Joint Project of Luzhou City-Southwest Medical University, China","award":["Grant No. 2023LZXNYDJ046"],"award-info":[{"award-number":["Grant No. 2023LZXNYDJ046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11010-025-05273-4","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T22:06:33Z","timestamp":1743717993000},"page":"4417-4429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts"],"prefix":"10.1007","volume":"480","author":[{"given":"Yang","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"6","key":"5273_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00395-020-00829-5","volume":"115","author":"P Golforoush","year":"2020","unstructured":"Golforoush P, Yellon DM, Davidson SM (2020) Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol 115(6):73","journal-title":"Basic Res Cardiol"},{"key":"5273_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, de Juan Abad BL, Cheng K (2021) Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev 173:504\u2013519","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"5273_CR3","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/ijms23052617","volume":"23","author":"K Maruyama","year":"2022","unstructured":"Maruyama K, Imanaka-Yoshida K (2022) The pathogenesis of cardiac fibrosis: a review of recent progress. Int J Mol Sci 23(5):2617","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5273_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","volume":"19","author":"N Mackman","year":"2020","unstructured":"Mackman N, Bergmeier W, Stouffer GA et al (2020) Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov 19(5):333\u2013352","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"5273_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","volume":"73","author":"T Doenst","year":"2019","unstructured":"Doenst T, Haverich A, Serruys P et al (2019) PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J Am Coll Cardiol 73(8):964\u2013976","journal-title":"J Am Coll Cardiol"},{"issue":"10318","key":"5273_CR6","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/S0140-6736(21)02334-5","volume":"398","author":"MS Sabatine","year":"2021","unstructured":"Sabatine MS, Bergmark BA, Murphy SA et al (2021) Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Lancet 398(10318):2247\u20132257","journal-title":"Lancet"},{"key":"5273_CR7","doi-asserted-by":"crossref","unstructured":"Viola M, de Jager SCA, Sluijter JPG (2021) Targeting inflammation after myocardial infarction: a therapeutic opportunity for extracellular vesicles?. Int J Mol Sci, 22(15)","DOI":"10.3390\/ijms22157831"},{"issue":"5","key":"5273_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/cvr\/cvaa287","volume":"117","author":"X Wu","year":"2021","unstructured":"Wu X, Reboll MR, Korf-Klingebiel M et al (2021) Angiogenesis after acute myocardial infarction. Cardiovasc Res 117(5):1257\u20131273","journal-title":"Cardiovasc Res"},{"key":"5273_CR9","doi-asserted-by":"publisher","first-page":"621644","DOI":"10.3389\/fcell.2020.621644","volume":"8","author":"AC Silva","year":"2021","unstructured":"Silva AC, Pereira C, Fonseca ACR, Pinto-do-\u00d3 P, Nascimento DS (2021) Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response. Front Cell Dev Biol 8:621644","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5273_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/eci.12195","volume":"44","author":"M Rigol","year":"2014","unstructured":"Rigol M, Solanes N, Roura S et al (2014) Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest 44(1):83\u201392","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"5273_CR11","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1002\/jcp.28381","volume":"234","author":"SM Parizadeh","year":"2019","unstructured":"Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M et al (2019) Stem cell therapy: a novel approach for myocardial infarction. J Cell Physiol 234(10):16904\u201316912","journal-title":"J Cell Physiol"},{"issue":"4","key":"5273_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jtcvs.2005.12.022","volume":"131","author":"JY Min","year":"2006","unstructured":"Min JY, Huang X, Xiang M et al (2006) Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiov Sur 131(4):889\u2013897","journal-title":"J Thorac Cardiov Sur"},{"issue":"3","key":"5273_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1253\/circj.CJ-09-0923","volume":"74","author":"XL Tang","year":"2010","unstructured":"Tang XL, Rokosh DG, Guo Y et al (2010) Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction [J]. Circ j 74(3):390\u2013404","journal-title":"Circ j"},{"issue":"10","key":"5273_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/14712598.2023.2245329","volume":"23","author":"D Clavellina","year":"2023","unstructured":"Clavellina D, Balkan W, Hare JM (2023) Stem cell therapy for acute myocardial infarction: mesenchymal stem cells and induced pluripotent stem cells. Expert Opin Biol Th 23(10):951\u2013967","journal-title":"Expert Opin Biol Th"},{"issue":"1","key":"5273_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang M, Yu Y et al (2023) Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction. Cell Commun Signal 21(1):202","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5273_CR16","first-page":"8031718","volume":"2018","author":"RE Fitzsimmons","year":"2018","unstructured":"Fitzsimmons RE, Mazurek MS, Soos A, Simmons CA (2018) Mesenchymal stromal\/stem cells in regenerative medicine and tissue engineering. Stem Cells Int 2018(1):8031718","journal-title":"Stem Cells Int"},{"issue":"1","key":"5273_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10059-010-0001-7","volume":"29","author":"J Tang","year":"2010","unstructured":"Tang J, Wang J, Guo L et al (2010) Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol Cells 29(1):9\u201319","journal-title":"Mol Cells"},{"key":"5273_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt394","volume":"5","author":"DS Nascimento","year":"2014","unstructured":"Nascimento DS, Mosqueira D, Sousa LM et al (2014) Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Therapy 5:1\u201314","journal-title":"Stem Cell Res Therapy"},{"issue":"6","key":"5273_CR19","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.ijcard.2012.06.052","volume":"167","author":"F Lu","year":"2013","unstructured":"Lu F, Zhao X, Wu J et al (2013) MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis. Int J Cardiol 167(6):2524\u20132532","journal-title":"Int J Cardiol"},{"issue":"2","key":"5273_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/07853890500422982","volume":"38","author":"KH Grinnemo","year":"2006","unstructured":"Grinnemo KH, M\u00e5nsson-Broberg A, Leblanc K et al (2006) Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Annals Med 38(2):144\u2013153","journal-title":"Annals Med"},{"issue":"8","key":"5273_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","volume":"109","author":"AR Williams","year":"2011","unstructured":"Williams AR, Hare JM (2011) Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109(8):923\u2013940","journal-title":"Circ Res"},{"issue":"2","key":"5273_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/jmcc.2001.1491","volume":"34","author":"J M\u00fcller-Ehmsen","year":"2002","unstructured":"M\u00fcller-Ehmsen J, Whittaker P, Kloner RA et al (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34(2):107\u2013116","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"5273_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0735-1097(03)00081-0","volume":"41","author":"FD Pagani","year":"2003","unstructured":"Pagani FD, Dersimonian H, Zawadzka A et al (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41(5):879\u2013888","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5273_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12032-013-0499-6","volume":"30","author":"H Cai","year":"2013","unstructured":"Cai H, Lin L, Cai H et al (2013) Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Med Oncol 30(2):499","journal-title":"Med Oncol"},{"issue":"4","key":"5273_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M, He H, Liang OD et al (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11(4):367\u2013368","journal-title":"Nat Med"},{"issue":"2","key":"5273_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.08.005","volume":"50","author":"M Mirotsou","year":"2011","unstructured":"Mirotsou M, Jayawardena TM, Schmeckpeper J et al (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50(2):280\u2013289","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"5273_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/CIRCRESAHA.115.305373","volume":"118","author":"CP Hodgkinson","year":"2016","unstructured":"Hodgkinson CP, Bareja A, Gomez JA et al (2016) Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res 118(1):95\u2013107","journal-title":"Circ Res"},{"issue":"9","key":"5273_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang X, Ding Y, Zhang Y et al (2014) Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant 23(9):1045\u20131059","journal-title":"Cell Transplant"},{"issue":"2","key":"5273_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.115.307654","volume":"118","author":"R Kishore","year":"2016","unstructured":"Kishore R, Khan M (2016) More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res 118(2):330\u2013343","journal-title":"Circ Res"},{"issue":"2","key":"5273_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCRESAHA.116.309307","volume":"120","author":"JH Jung","year":"2017","unstructured":"Jung JH, Fu X, Yang PC (2017) Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases. Circ Res 120(2):407\u2013417","journal-title":"Circ Res"},{"issue":"1","key":"5273_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s11671-021-03559-2","volume":"16","author":"Q Li","year":"2021","unstructured":"Li Q, Jin Y, Ye X et al (2021) Bone marrow mesenchymal stem cell-derived exosomal MicroRNA-133a restrains myocardial fibrosis and epithelial-mesenchymal transition in viral myocarditis rats through suppressing MAML1. Nanoscale Res Lett 16(1):111","journal-title":"Nanoscale Res Lett"},{"issue":"7","key":"5273_CR32","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/thno.52677","volume":"11","author":"TL Lee","year":"2021","unstructured":"Lee TL, Lai TC, Lin SR et al (2021) Conditioned medium from adipose-derived stem cells attenuates ischemia\/reperfusion-induced cardiac injury through the microRNA-221\/222\/PUMA\/ETS-1 pathway. Theranostics 11(7):3131\u20133149","journal-title":"Theranostics"},{"issue":"22","key":"5273_CR33","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.7150\/thno.28021","volume":"8","author":"LP Zhu","year":"2018","unstructured":"Zhu LP, Tian T, Wang JY et al (2018) Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics 8(22):6163\u20136177","journal-title":"Theranostics"},{"issue":"3","key":"5273_CR34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jcmm.13492","volume":"22","author":"C Hu","year":"2018","unstructured":"Hu C, Li L (2018) Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med 22(3):1428\u20131442","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5273_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/0963689718755404","volume":"27","author":"GJ Moon","year":"2018","unstructured":"Moon GJ, Cho YH, Kim DH et al (2018) Serum-mediated activation of bone marrow-derived mesenchymal stem cells in ischemic stroke patients: a novel preconditioning method. Cell Transplant 27(3):485\u2013500","journal-title":"Cell Transplant"},{"issue":"8","key":"5273_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3727\/096368916X690430","volume":"25","author":"EH Kim","year":"2016","unstructured":"Kim EH, Kim DH, Kim HR et al (2016) Stroke serum priming modulates characteristics of mesenchymal stromal cells by controlling the expression miRNA-20a. Cell Transplant 25(8):1489\u20131499","journal-title":"Cell Transplant"},{"key":"5273_CR37","doi-asserted-by":"publisher","first-page":"175238","DOI":"10.1016\/j.ejphar.2022.175238","volume":"933","author":"Y Fu","year":"2022","unstructured":"Fu Y, Shi J, Qian H et al (2022) Alleviation of cardiac fibrosis using acellular peritoneal matrix-loaded pirfenidone nanodroplets after myocardial infarction in rats. Eur J Pharmacol 933:175238","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5273_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000456531","volume":"41","author":"H Shi","year":"2017","unstructured":"Shi H, Zhang X, He Z et al (2017) Metabolites of hypoxic cardiomyocytes induce the migration of cardiac fibroblasts. Cell Physiol Biochem 41(1):413\u2013421","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"5273_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119(1):91\u2013112","journal-title":"Circ Res"},{"key":"5273_CR40","doi-asserted-by":"crossref","unstructured":"Hohn J, Tan W, Carver A, et al. (2021) Roles of exosomes in cardiac fibroblast activation and fibrosis. Cells, 10(11)","DOI":"10.3390\/cells10112933"},{"issue":"5","key":"5273_CR41","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang C, Batkai S, Dangwal S et al (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124(5):2136\u20132146","journal-title":"J Clin Invest"},{"issue":"4","key":"5273_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10741-019-09770-9","volume":"24","author":"M Dutka","year":"2019","unstructured":"Dutka M, Bobi\u0144ski R, Korbecki J (2019) The relevance of microRNA in post-infarction left ventricular remodelling and heart failure. Heart Fail Rev 24(4):575\u2013586","journal-title":"Heart Fail Rev"},{"issue":"2","key":"5273_CR43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3892\/etm.2021.10305","volume":"22","author":"QG Wang","year":"2021","unstructured":"Wang QG, Cheng BC, He YZ et al (2021) miR-320a in serum exosomes promotes myocardial fibroblast proliferation via regulating the PIK3CA\/Akt\/mTOR signaling pathway in HEH2 cells. Exp Ther Med 22(2):873","journal-title":"Exp Ther Med"},{"issue":"6","key":"5273_CR44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.recesp.2017.06.024","volume":"71","author":"C R\u00edos-Navarro","year":"2018","unstructured":"R\u00edos-Navarro C, Hueso L, Mi\u00f1ana G et al (2018) Coronary serum obtained after myocardial infarction induces angiogenesis and microvascular obstruction repair. Role of hypoxia-inducible factor-1A. Rev Esp Cardiol 71(6):440\u2013449","journal-title":"Rev Esp Cardiol"},{"key":"5273_CR45","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2147\/IJN.S242908","volume":"15","author":"T Geng","year":"2020","unstructured":"Geng T, Song ZY, Xing JX et al (2020) Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143\/IGF-IR pathway. Int J Nanomed 15:2647\u20132658","journal-title":"Int J Nanomed"},{"issue":"16","key":"5273_CR46","doi-asserted-by":"publisher","first-page":"C81","DOI":"10.1016\/j.jacc.2015.06.324","volume":"66","author":"W Zhang","year":"2015","unstructured":"Zhang W, Ji F (2015) GW26-e4563 serum level of fibroblast growth factor 21 is independently associated with acute myocardial infarction. J Am Coll Cardiol 66(16):C81","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5273_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1062-1458(01)00230-6","volume":"10","author":"D Morrow","year":"2001","unstructured":"Morrow D, Antman E, Tanasijevic M (2001) Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. ACC Curr J Rev 10(3):16","journal-title":"ACC Curr J Rev"},{"issue":"1\u20132","key":"5273_CR48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/mgme.2000.3032","volume":"71","author":"PJ Lijnen","year":"2000","unstructured":"Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71(1\u20132):418\u2013435","journal-title":"Mol Genet Metab"},{"issue":"2","key":"5273_CR49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ymthe.2017.11.008","volume":"26","author":"KO B\u00f6ker","year":"2018","unstructured":"B\u00f6ker KO, Lemus-Diaz N, Rinaldi Ferreira R et al (2018) The impact of the CD9 tetraspanin on lentivirus infectivity and exosome secretion. Mol Ther 26(2):634\u2013647","journal-title":"Mol Ther"},{"issue":"22","key":"5273_CR50","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1042\/CS20190578","volume":"133","author":"SR Anthony","year":"2019","unstructured":"Anthony SR, Guarnieri AR, Gozdiff A et al (2019) Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis. Clin Sci 133(22):2329\u20132344","journal-title":"Clin Sci"},{"key":"5273_CR51","doi-asserted-by":"crossref","unstructured":"Tikhomirov R, Donnell B R, Catapano F, et al. (2020) Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis. Cells, 9(3)","DOI":"10.3390\/cells9030592"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05273-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:20:15Z","timestamp":1757161215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5273"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05273-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Southwest Medical University (20230817-006). The animals were treated humanely.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}